- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-50-0066825

Glalet Pharmaceuticals Private Limited
About Glalet Pharmaceuticals Private Limited
Data last updated:
Glalet Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 24 June 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2022PTC166358.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Glatt Pharmaceuticals Private Limited. It is led by directors Anchal Srivastava (Whole-Time Director) and Prashant Sen Srivastava (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 304 3rd Floor Rohit Tower Haniman Chauraha Cp – 1 Viraj Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.1 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹7.07 Lakh (net margin 3.4%) and EBITDA of ₹12.27 Lakh (EBITDA margin 5.8%).
The company is associated with 1 brand: Glattpharma. As per MCA filings, the company has open charges of ₹80 Lakh on record.
Glalet Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0066825).
Company details
Recognitions & Rankings of Glalet Pharmaceuticals
Contact details
Glalet Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered Address304 3rd Floor Rohit Tower Haniman Chauraha Cp – 1 Viraj Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Glalet Pharmaceuticals operates one associated brand: Glattpharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| glattpharma.in |
Business activity
The main business activity of Glalet Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Glalet Pharmaceuticals Private Limited, buy the company report.
Financials of Glalet Pharmaceuticals Private Limited
FY 2025 filings availableGlalet Pharmaceuticals Private Limited reported revenue of ₹2.1 Cr (up 552% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 552% in the latest year. EBITDA rose 212% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹12.27 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹7.07 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.8% | |
| Net Profit Margin | 3.4% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Glalet Pharmaceuticals Private Limited, buy the company report.
Board of directors of Glalet Pharmaceuticals Private Limited
Glalet Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anchal Srivastava | Whole-Time Director | 24 Jun 2022 | 4 Years 4 Months | Current |
| Prashant Sen Srivastava | Whole-Time Director | 24 Jun 2022 | 4 Years 4 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Nov 2023 | 100818549 | Others | ₹70 Lakh | Open | |
| 19 Jul 2023 | 100762172 | Others | ₹10 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Glalet Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glalet Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Glalet Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Glalet Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Anchal Srivastava was appointed as Whole-Time Director on 24 Jun 2022.
Frequently asked questions
Glalet Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 24 June 2022 (4+ years old) and is registered under CIN U51909UP2022PTC166358.
Glalet Pharmaceuticals has 2 current directors:
- Anchal Srivastava - Whole-Time Director
- Prashant Sen Srivastava - Whole-Time Director
The latest financial statements of Glalet Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Glalet Pharmaceuticals is U51909UP2022PTC166358. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glalet Pharmaceuticals was incorporated on 24 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Anchal Srivastava was appointed as Whole-Time Director on 24 Jun 2022. Prashant Sen Srivastava was appointed as Whole-Time Director on 24 Jun 2022.
Yes, Glalet Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0066825).
The registered office of Glalet Pharmaceuticals is at 304 3rd Floor Rohit Tower Haniman Chauraha Cp – 1 Viraj Khand Gomti Nagar, Lucknow, Uttar Pradesh, India – 226010.
Glalet Pharmaceuticals operates in the trading industry, in the specialty segment.
Glalet Pharmaceuticals has open charges of ₹80 Lakh and no satisfied charges on record as per latest MCA filings.

